CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease

Thomas Magg, Anna Shcherbina, Duran Arslan, Mukesh Desai, Sarah Wall, Vanessa Mitsialis, Raffaele Conca, Ekrem Ünal, Neslihan Karacabey, Anna Mukhinа,

Inflammatory Bowel Diseases · 2019 · 33 citations · 22 references

DOIFull text

Open access

Concepts

Abstract

BACKGROUND: Children with very early onset inflammatory bowel diseases (VEO-IBD) often have a refractory and severe disease course. A significant number of described VEO-IBD-causing monogenic disorders can be attributed to defects in immune-related genes. The diagnosis of the underlying primary immunodeficiency (PID) often has critical implications for the treatment of patients with IBD-like phenotypes. METHODS: To identify the molecular etiology in 5 patients from 3 unrelated kindred with IBD-like symptoms, we conducted whole exome sequencing. Immune workup confirmed an underlying PID. RESULTS: Whole exome sequencing revealed 3 novel CARMIL2 loss-of-function mutations in our patients. Immunophenotyping of peripheral blood mononuclear cells showed reduction of regulatory and effector memory T cells and impaired B cell class switching. The T cell proliferation and activation assays confirmed defective responses to CD28 costimulation, consistent with CARMIL2 deficiency. CONCLUSION: Our study highlights that human CARMIL2 deficiency can manifest with IBD-like symptoms. This example illustrates that early diagnosis of underlying PID is crucial for the treatment and prognosis of children with VEO-IBD.

References

22